The estimated Net Worth of Allison M Jeynes Ellis is at least $781 Tausend dollars as of 16 June 2021. Allison Ellis owns over 16,853 units of Agenus Inc stock worth over $373,233 and over the last 6 years he sold AGEN stock worth over $0. In addition, he makes $407,935 as Independent Director at Agenus Inc.
Allison has made over 2 trades of the Agenus Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 16,853 units of AGEN stock worth $95,051 on 16 June 2021.
The largest trade he's ever made was exercising 20,338 units of Agenus Inc stock on 19 June 2020 worth over $114,706. On average, Allison trades about 3,381 units every 33 days since 2018. As of 16 June 2021 he still owns at least 66,176 units of Agenus Inc stock.
You can see the complete history of Allison Ellis stock trades at the bottom of the page.
Dr. Allison M. Jeynes-Ellis M.D. serves as Independent Director of the Company. Dr. Jeynes-Ellis is a trained clinician with more than 25 years of senior leadership experience in the pharmaceutical industry. Dr. Jeynes-Ellis is the Chief Executive Officer and a Director of Avillion LLP (“Avillion”), a London-based drug development company. Prior to her current position as CEO, Dr. Jeynes-Ellis served as Avillion’s Chief Medical Officer from December 2012 to January 2014. Before her tenure at Avillion, Dr. Jeynes-Ellis worked in senior roles at Wyeth, Bristol-Myers Squibb, and Novartis. Her previous affiliations also include Cambridge Antibody Technology and Genentech, government bodies and medical charities. She has managed teams focusing on global clinical development projects that have led to drug approvals in Europe and the United States, across a range of therapeutic areas. Dr. Jeynes-Ellis currently serves as a Senior Advisor to Blackstone Life Sciences.
As the Independent Director of Agenus Inc, the total compensation of Allison Ellis at Agenus Inc is $407,935. There are 10 executives at Agenus Inc getting paid more, with Garo Armen having the highest compensation of $9,937,040.
Allison Ellis is 54, he's been the Independent Director of Agenus Inc since 2018. There are 10 older and 2 younger executives at Agenus Inc. The oldest executive at Agenus Inc is Wadih Jordan, 85, who is the Independent Director.
Allison's mailing address filed with the SEC is C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON, MA, 02421.
Over the last 23 years, insiders at Agenus Inc have traded over $24,466,328 worth of Agenus Inc stock and bought 13,248,226 units worth $63,837,873 . The most active insiders traders include Associates Gp Llcqvt Fund V..., Noubar Afeyan und Corp Incyte. On average, Agenus Inc executives and independent directors trade stock every 99 days with the average trade being worth of $2,230,885. The most recent stock trade was executed by Garo H Armen on 15 February 2024, trading 500,000 units of AGEN stock currently worth $325,000.
agenus is an immunology company discovering and developing novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. we are a dedicated group of scientists, researchers, biotechnologists, physicians, and businesspeople working together toward one goal: to discover and develop therapies that can unleash the innate power of the body’s immune system to treat and potentially cure hard-to-treat cancers and other diseases. our product candidates are designed to work by educating and activating the body’s immune system for a precise and potent attack on cancer. our strategy is to help unlock the potential of one of the most exciting breakthrough areas in cancer treatment in decades, and to develop single agent and combination immune-oncology therapies that can help save lives. our approaches are driven by three platform technologies, including: • our antibody platforms, including our proprietary retrocyte display™ and secant® technologies, and our antibody
Agenus Inc executives and other stock owners filed with the SEC include: